ANRS 0146s NovaaTen study aims to determine the vaccine responses in the participants of the ANRS EP46 Novaa trial 10 years after a primary anti-yellow fever vaccination
40 HIV positive subjects from consultations for infectious diseases and travel medicine centers at Saint-Louis, Cochin-Pasteur and Bichat hospitals (on HAART for at least one year and not modified in the 3 months preceding the pre-inclusion visit, CD4 > 350/mm3 and a viral load <50 copies / mL for at least 6 months).
20 HIV negative subjects from the consultation of travelers from Saint-Louis, Bichat and Cochin-Pasteur hospitals.
Subjects agreeing to be monitored according to the terms of the protocol.
Subjects affiliated to a Social Security scheme or beneficiaries of such a scheme.
Non-volunteers for the 10-year follow-up
Subject under curatorship, guardianship or safeguard of justice.
ANRS, Emerging Infectious Diseases
Lead sponsor
Saint-Louis Hospital, Paris, France
Collaborator
Bichat Hospital
Collaborator
Hôpital Cochin
Collaborator